Exsulin Corporation Report issue

For profit Phase 2
Founded: Burnsville MN United States (2006)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2006
NCT00071409
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

ec-18 (1 trial)

ingap peptide (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Mucositis (Phase 2)

Stomatitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 2